The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

Many people use the terms ‘migraine’ and ‘headache’ interchangeably. This leads many people to believe that migraines are not ...

That's concerning, because "without a proper diagnosis, medications that can help reduce migraine may be delayed," noted study author Dr. Marissa Maliakal Anto of the University of Pennsylvania in ...

Ubrelvy (ubrogepant) and Nurtec (rimegepant) are prescription medications approved to help manage and offer relief for people dealing with migraine headaches with or without aura. Both belong to a ...

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free after repaying mortgage on facilities ...

Migraine costs the U.S. economy more than $23 billion each year. The Migraine Research Program at Mayo Clinic focuses on better understanding and treatment of this common, functionally complex and ...

Connecticut Pain Solutions is excited to announce the availability of its cutting-edge Platelet-Rich Plasma (PRP) treatments.

Vanessa Kanu Kanu; Executive Vice President and Chief Financial Officer; Aptargroup Inc Ladies and gentlemen, thank you for standing by. Welcome to Aptar 2024 fourth quarter and annual results ...

Keeping a headache diary can help identify the specific causes or your migraines. In addition, there are numerous medications available to treat migraines. These include pain-relieving medications and ...